← board
SDGR
distress 0/10 · well-funded / low risk$15.20+1%today-34% from 52w high
Revenue
$59M
Liquidity
$399M
Runway
2.8 yrs
Shares 1y
—
Price & events
-12.3% over 6M
CatalystRating changeDilutionFinancingdashed = today
+1.1%
1D
-2.6%
1W
+1.1%
1M
+33.2%
3M
-7.4%
6M
-34.0%
1Y
-33.0%
2Y
-78.2%
5Y
-80.9%
All
Overview
- Volume
- 56.13K
- 52 Week Range
- $11.07 – $23.03
- Float Shares
- 57.65M
- Short %
- 25.09%
- % Held by Insiders
- 3.01%
- % Held by Institutions
- 98.22%
- RVOL
- 0.05x
- Beta
- 1.62
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-05Estimated 45%earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
buy · target $21 (+35% upside) · 7 analysts
- 2026-05-14Morgan StanleyEqual-Weight
- 2026-04-08KeybancOverweight
- 2026-03-17UBSNeutral
- 2026-01-08KeybancOverweight
- 2026-01-08TD CowenBuy
- 2026-01-07UBSNeutral
Competitors
- none identified
Recent news
- 2026-07-22Enterprise value to revenue forward of Schrodinger, Inc. – FWB:43Z - TradingView
- 2026-07-20Schrodinger (SDGR) Grants Restricted Stock Units to New Employees - GuruFocus
- 2026-07-18Form 4 Schrodinger Inc For: 17 July By Investing.com - Investing.com Nigeria
- 2026-07-17Schrodinger CFO Rachit Jain sells $13,647 in stock - Investing.com
- 2026-07-17Schrodinger (SDGR) CFO sells 875 shares for RSU tax withholding - Stock Titan
- 2026-07-17Enterprise value to revenue forward of Schrodinger, Inc. – DUS:43Z - TradingView
- 2026-07-09Schrodinger Inc. (SDGR) Jumps 3.73% as Software-Driven Drug Discovery Gains Traction - Gap and Reverse - dars.gov.et
- 2026-07-09Schrodinger Inc. (SDGR) Jumps 3.73% as Software-Driven Drug Discovery Gains Traction - Watchlist Stock Ideas - dars.gov.et
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.